Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EVH | US
-0.16
-3.65%
Healthcare
Health Information Services
30/06/2024
05/06/2026
4.22
4.38
4.44
4.13
Evolent Health Inc. a healthcare company through its subsidiary Evolent Health LLC offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services such as health plan services risk management analytics and reporting and leadership and management; and Identifi a proprietary technology system that aggregates and analyzes data manages care workflows and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care independent of their stage of maturation and specific market dynamics in oncology cardiology and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington Virginia.
View LessPositive Momentum
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
103.2%1 month
84.7%3 months
85.0%6 months
77.7%-
14.04
2.75
0.78
0.33
52.14
1.46
-1.37
136.26M
490.74M
490.74M
-
1.46
-
37.90
-5.94
8.06
12.27
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.77
Range1M
0.98
Range3M
2.44
Rel. volume
0.74
Price X volume
8.69M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| National Research Corporation | NRC | Diagnostics & Research | 19.14 | 456.90M | -3.09% | 16.76 | 105.03% |
| FRP Holdings Inc | FRPH | Real Estate Services | 23.54 | 447.98M | -0.21% | 75.50 | 42.65% |
| Myriad Genetics Inc | MYGN | Diagnostics & Research | 4.57 | 415.05M | -2.56% | n/a | 0.00% |
| Varex Imaging Corporation | VREX | Diagnostics & Research | 10.09 | 412.29M | -3.54% | 16.69 | 80.92% |
| Pacific Biosciences of California Inc | PACB | Diagnostics & Research | 1.45 | 395.17M | -11.04% | n/a | 187.73% |
| The RMR Group Inc | RMR | Real Estate Services | 20.29 | 339.35M | -0.34% | 16.64 | 14.14% |
| The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 1.68 | 332.23M | 3.70% | n/a | 0.00% |
| SOPHiA GENETICS SA Ordinary Shares | SOPH | Health Information Services | 5 | 327.35M | 0.81% | n/a | 24.76% |
| Simulations Plus Inc | SLP | Health Information Services | 15.88 | 317.72M | -4.62% | 71.15 | 0.51% |
| Delcath Systems Inc | DCTH | Diagnostics & Research | 10.67 | 298.77M | -1.11% | n/a | 133.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| NACCO Industries Inc | NC | Coal | 53.21 | 391.26M | 2.31% | n/a | 17.95% |
| OPAL Fuels Inc | OPAL | Utilities-Regulated Gas | 2.095 | 362.06M | -9.31% | 48.00 | -86.74% |
| RGC Resources Inc | RGCO | Utilities-Regulated Gas | 22.93 | 234.32M | 2.37% | 16.84 | 133.09% |
| New Fortress Energy LLC | NFE | Utilities-Regulated Gas | 0.5034 | 126.56M | -6.41% | 7.76 | 498.90% |
| White Energy Company Limited | WECFF | Coal | 0.1571 | 31.26M | 9.71% | n/a | -2054.06% |
| Tantech Holdings Ltd | TANH | Coal | 0.42 | 3.50M | -1.20% | 0.09 | 6.96% |
| Watford Holdings Ltd | WTRE | Insurance - Diversified | 25.6309 | 0 | -3.56% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 52.14 | 15.88 | Expensive |
| Ent. to Revenue | 1.46 | 14.90 | Cheaper |
| PE Ratio | - | 64.03 | - |
| Price to Book | 2.75 | 6.17 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 85.04 | 64.72 | Riskier |
| Debt to Equity | 0.78 | 0.44 | Expensive |
| Debt to Assets | 0.33 | 0.35 | Par |
| Market Cap | 490.74M | 3.23B | Emerging |